These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35305865)

  • 1. Dominant negative effects of SCN5A missense variants.
    O'Neill MJ; Muhammad A; Li B; Wada Y; Hall L; Solus JF; Short L; Roden DM; Glazer AM
    Genet Med; 2022 Jun; 24(6):1238-1248. PubMed ID: 35305865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Ishikawa T; Kimoto H; Mishima H; Yamagata K; Ogata S; Aizawa Y; Hayashi K; Morita H; Nakajima T; Nakano Y; Nagase S; Murakoshi N; Kowase S; Ohkubo K; Aiba T; Morimoto S; Ohno S; Kamakura S; Nogami A; Takagi M; Karakachoff M; Dina C; Schott JJ; Yoshiura KI; Horie M; Shimizu W; Nishimura K; Kusano K; Makita N
    Eur Heart J; 2021 Jul; 42(29):2854-2863. PubMed ID: 34219138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.
    Tan BY; Yong RY; Barajas-Martinez H; Dumaine R; Chew YX; Wasan PS; Ching CK; Ho KL; Gan LS; Morin N; Chong AP; Yap SH; Neo JL; Yap EP; Moochhala S; Chong DT; Chow W; Seow SC; Hu D; Uttamchandani M; Teo WS
    Europace; 2016 Jun; 18(6):897-904. PubMed ID: 25829473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
    J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome.
    Hu D; Barajas-Martínez H; Pfeiffer R; Dezi F; Pfeiffer J; Buch T; Betzenhauser MJ; Belardinelli L; Kahlig KM; Rajamani S; DeAntonio HJ; Myerburg RJ; Ito H; Deshmukh P; Marieb M; Nam GB; Bhatia A; Hasdemir C; Haïssaguerre M; Veltmann C; Schimpf R; Borggrefe M; Viskin S; Antzelevitch C
    J Am Coll Cardiol; 2014 Jul; 64(1):66-79. PubMed ID: 24998131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.
    Zeng Z; Zhou J; Hou Y; Liang X; Zhang Z; Xu X; Xie Q; Li W; Huang Z
    PLoS One; 2013; 8(10):e78382. PubMed ID: 24167619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand.
    Makarawate P; Glinge C; Khongphatthanayothin A; Walsh R; Mauleekoonphairoj J; Amnueypol M; Prechawat S; Wongcharoen W; Krittayaphong R; Anannab A; Lichtner P; Meitinger T; Tjong FVY; Lieve KVV; Amin AS; Sahasatas D; Ngarmukos T; Wichadakul D; Payungporn S; Sutjaporn B; Wandee P; Poovorawan Y; Tfelt-Hansen J; Tanck MWT; Tadros R; Wilde AAM; Bezzina CR; Veerakul G; Nademanee K
    Heart Rhythm; 2020 Dec; 17(12):2145-2153. PubMed ID: 32619740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-Regulation of K
    Clatot J; Neyroud N; Cox R; Souil C; Huang J; Guicheney P; Antzelevitch C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Analysis of SCN5A Genetic Variants Associated with Brugada Syndrome.
    Mikhailova VB; Karpushev AV; Vavilova VD; Klimenko ES; Tulintseva T; Yudina YS; Vasichkina ES; Zhorov BS; Kostareva A
    Cardiology; 2022; 147(1):35-46. PubMed ID: 34628415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput Reclassification of SCN5A Variants.
    Glazer AM; Wada Y; Li B; Muhammad A; Kalash OR; O'Neill MJ; Shields T; Hall L; Short L; Blair MA; Kroncke BM; Capra JA; Roden DM
    Am J Hum Genet; 2020 Jul; 107(1):111-123. PubMed ID: 32533946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
    Núñez L; Barana A; Amorós I; de la Fuente MG; Dolz-Gaitón P; Gómez R; Rodríguez-García I; Mosquera I; Monserrat L; Delpón E; Caballero R; Castro-Beiras A; Tamargo J
    Heart Rhythm; 2013 Feb; 10(2):264-72. PubMed ID: 23085483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannitol and hyponatremia regulate cardiac ventricular conduction in the context of sodium channel loss of function.
    Blair GA; Wu X; Bain C; Warren M; Hoeker GS; Poelzing S
    Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H724-H734. PubMed ID: 38214908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness.
    Samani K; Wu G; Ai T; Shuraih M; Mathuria NS; Li Z; Sohma Y; Purevjav E; Xi Y; Towbin JA; Cheng J; Vatta M
    Heart Rhythm; 2009 Sep; 6(9):1318-26. PubMed ID: 19648062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative effect of SCN5A N-terminal mutations through the interaction of Na(v)1.5 α-subunits.
    Clatot J; Ziyadeh-Isleem A; Maugenre S; Denjoy I; Liu H; Dilanian G; Hatem SN; Deschênes I; Coulombe A; Guicheney P; Neyroud N
    Cardiovasc Res; 2012 Oct; 96(1):53-63. PubMed ID: 22739120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents.
    Aiba T; Farinelli F; Kostecki G; Hesketh GG; Edwards D; Biswas S; Tung L; Tomaselli GF
    Circ Cardiovasc Genet; 2014 Jun; 7(3):249-56. PubMed ID: 24795344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.
    Joviano-Santos JV; Santos-Miranda A; Neri EA; Fonseca-Alaniz MH; Krieger JE; Pereira AC; Roman-Campos D
    Life Sci; 2021 Aug; 278():119646. PubMed ID: 34048814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.